Author

Seshadri S. Vasan

Edith Cowan UniversityORCID 0000-0002-7326-3210Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Microbiology· 1 Molecular Biology· 1 Scientific Communication & Education· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Alexander J. McAuleyiD· 2 shared Mohammed Muzaffar-Ur-Rehman· 2 shared Stephanie Olliff· 2 shared Abha MaheshwariiD· 1 shared Aditya V. VashiiD· 1 shared Anupama KumariD· 1 shared Ashish Awasthi· 1 shared Bang M. TraniD· 1 shared

Activity by Year

2021-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Alexander J. McAuleyORCID

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Experimental validation of computationally prioritized bisphosphonates reveals no direct in vitro antiviral activity against SARS-CoV-2

Mohammed Muzaffar-Ur-Rehman, Stephanie Olliff, Alexander J. McAuley, Ashish Awasthi, Kondapalli Venkata Gowri Chandrasekhar, Murugesan Sankranarayanan, Seshadri S. Vasan

This study evaluates the antiviral potential of bisphosphonates and treprostinil in vitro against SARS-CoV-2 but finds no direct antiviral activity.

bioRxiv · Sep 8, 2026 · PreprintMolecular Biology

Participatory development of innovation and implementation strategy - a practical approach

Miae Lee, Lesley Ann Anderson, Emilia Piltonen, Abha Maheshwari, Julian L. Griffin, Seshadri Vasan

The paper describes a participatory workshop approach to strategic planning in healthcare, identifying key themes and actionable strategies through stakeholder input and structured analysis tools.

BMC Health Services Research · Mar 25, 2026Peer-reviewedScientific Communication & Education

Use of Stem Cell-Derived Cardiomyocyte and Nasal Epithelium Models to Establish a Multi-Tissue Model Platform to Validate Repurposed Drugs Against SARS-CoV-2 Infection

Nathan Gödde, Carmel O’Brien, Elizabeth Vincan, Aditya V. Vashi, Stephanie Olliff, Bang M. Tran, Shafagh A. Waters, Sarah Goldie, Petrus Jansen van Vuren, Shane Riddell, Matthew P. Bruce, Vinti Agarwal, Eugene Athan, Kim R. Blasdell, Simran Chahal, , Seshadri S. Vasan

The paper validates repurposed drugs against SARS-CoV-2 using stem cell-derived cardiomyocyte and nasal epithelium models, confirming fluvoxamine's antiviral efficacy in combination with other drugs.

bioRxiv · May 22, 2024 · PreprintMicrobiology

But Mouse, you are not alone: On some severe acute respiratory syndrome coronavirus 2 variants infecting mice

Michael J. Kuiper, Laurence O W Wilson, Shruthi Mangalaganesh, Carol M. Lee, Daniel Reti, Seshadri S. Vasan

The paper identifies SARS-CoV-2 variants that can infect mice and suggests targeted surveillance in specific countries due to potential human-mouse virus transmission.

ILAR Journal · Jan 1, 2021Peer-reviewedBioinformatics